N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine CAS 231278-20-9: High Purity Pharmaceutical Intermediate Manufacturer & Supplier

Source high-purity N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine (CAS 231278-20-9) for your pharmaceutical synthesis needs. As a trusted manufacturer and supplier in China, we provide critical intermediates like this quinazoline derivative, essential for the development of advanced APIs. We offer competitive pricing and reliable supply to support your R&D and production timelines.

Get a Quote & Sample

Why Choose Our Pharmaceutical Intermediate?

Uncompromised Purity

Our N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine (CAS 231278-20-9) consistently achieves a purity of ≥99%, meeting the stringent requirements for pharmaceutical intermediates and enabling reliable results in kinase inhibitor synthesis.

Consistent Supply Chain

As a dedicated manufacturer and supplier from China, we prioritize supply chain stability. You can count on us for a steady provision of this essential fine chemical to support your ongoing production needs.

Expertise in Pharmaceutical Synthesis

Leveraging our deep understanding of pharmaceutical intermediates and API synthesis, we provide not just a product, but a solution. Our chemical expertise ensures you receive a high-quality quinazoline derivative for your critical applications.

Key Applications and Benefits

API Synthesis

This intermediate is a key building block for synthesizing various Active Pharmaceutical Ingredients (APIs), particularly those involving quinazoline structures, crucial for targeted therapies.

Kinase Inhibitor Development

Its specific chemical structure makes it highly valuable in the research and development of kinase inhibitors, a vital class of drugs in cancer therapy and other medical treatments.

Advanced Organic Synthesis

As a sophisticated fine chemical, it empowers complex organic synthesis projects, offering chemists a reliable starting material for novel molecule creation.

R&D and Pharmaceutical Manufacturing

From laboratory research to pilot-scale production, this intermediate is essential for pharmaceutical manufacturers and research institutions seeking high-grade materials.